Self-medication and knowledge among pregnant women attending primary healthcare services in Malang, Indonesia: a cross-sectional study

[1] Lagoy CT(2005)Report from the CDC: medication use during pregnancy and lactation: an urgent call for public health action J Women's Health 14 104-109

[2] Joshi N(2014)Medication use in pregnancy: a cross-sectional, multinational web-based study BMJ Open 4 e004365-344

[3] Cragan JD(1986)Illegal abortion in southern Ghana: methods, Motives and Consequences Human Organization 45 333-829

[4] Rasmussen SA(2006)Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis Ann Pharmacother 40 824-2415

[5] Lupattelli A(1990)The federal regulation of prescription drug advertising and promotion JAMA 264 2409-277

[6] Spigset O(2008)Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population Pharmacoepidemiol Drug Saf 17 270-204

[7] Twigg M J(1990)Self-medication in developing countries J Soc Administr Pharmacy 7 199-777

[8] Zagorodnikova K(1982)Maternal VALPROIC acid and congenital neural tube defects Lancet 320 937-8

[9] Mårdby A C(2005)Use of over-the-counter medications during pregnancy Am J Obstet Gynecol 193 771-417

[10] Moretti M E(2013)Prevalence and predictors of over-the-counter medication use among pregnant women: A cross-sectional study in the Netherlands BMC Public Health 13 185-71

[1] Lagoy CT(2005)Report from the CDC: medication use during pregnancy and lactation: an urgent call for public health action J Women's Health 14 104-109

[2] Joshi N(2014)Medication use in pregnancy: a cross-sectional, multinational web-based study BMJ Open 4 e004365-344

[3] Cragan JD(1986)Illegal abortion in southern Ghana: methods, Motives and Consequences Human Organization 45 333-829

[4] Rasmussen SA(2006)Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis Ann Pharmacother 40 824-2415

[5] Lupattelli A(1990)The federal regulation of prescription drug advertising and promotion JAMA 264 2409-277

[6] Spigset O(2008)Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population Pharmacoepidemiol Drug Saf 17 270-204

[7] Twigg M J(1990)Self-medication in developing countries J Soc Administr Pharmacy 7 199-777

[8] Zagorodnikova K(1982)Maternal VALPROIC acid and congenital neural tube defects Lancet 320 937-8

[9] Mårdby A C(2005)Use of over-the-counter medications during pregnancy Am J Obstet Gynecol 193 771-417

[10] Moretti M E(2013)Prevalence and predictors of over-the-counter medication use among pregnant women: A cross-sectional study in the Netherlands BMC Public Health 13 185-71